INT177975

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2004
Last Reported 2004
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.22
Pain Relevance 0.07

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

molecular_function (TNXA) cellular_component (TNXA) biological_process (TNXA)
Anatomy Link Frequency
head 2
TNXA (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 14 94.20 High High
Bioavailability 2 13.44 Low Low
aspirin 4 5.00 Very Low Very Low Very Low
beta blocker 2 5.00 Very Low Very Low Very Low
epidural 2 5.00 Very Low Very Low Very Low
depression 2 5.00 Very Low Very Low Very Low
Angina 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Renal Insufficiency 10 95.20 Very High Very High Very High
Cv General 3 Under Development 14 94.20 High High
Heart Rate Under Development 4 88.16 High High
Myocardial Infarction 10 87.04 High High
Death 10 85.52 High High
Renal Failure 12 83.80 Quite High
Renal Disease 20 82.64 Quite High
Cardiovascular Disease 8 79.92 Quite High
Stroke 8 78.32 Quite High
Coronary Artery Disease 6 77.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The Nadroparin calcium Versus Enoxaparin (NaVe) Study will evaluate in a head to head basis the anti Xa activity reached by nadroparine or enoxaparine, both low molecular weight heparins, in patients at high risk for ischemic episodes, and renal insufficiency to eventually be undergone to angiographic diagnosis studies, and in consequence proposing the best anticoagulant strategies for these patients before being invasively treated.
Positive_regulation (reached) of anti Xa in head associated with renal insufficiency
1) Confidence 0.01 Published 2004 Journal Thromb J Section Abstract Doc Link PMC425600 Disease Relevance 1.00 Pain Relevance 0.05
The The Nadroparin calcium Versus Enoxaparin (NaVe) Study will evaluate in a head to head basis the anti Xa activity reached by nadroparine or enoxaparine, both low molecular weight heparins, in patients at high risk for ischemic episodes, and renal insufficiency to eventually be undergone to angiographic diagnosis studies, and in consequence proposing the best anticoagulant strategies for these patients before being invasively treated.
Positive_regulation (reached) of anti Xa in head associated with renal insufficiency
2) Confidence 0.01 Published 2004 Journal Thromb J Section Body Doc Link PMC425600 Disease Relevance 0.22 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox